Data integrity is an ongoing concern across all R&D organizations, no matter what part of the research lifecycle they’re navigating. These concerns extend beyond the potential for delayed timelines or ...

Cathy Burgess, Benjamin Wolf, Jong Ho "Philip" Won, Ph.D. The Food and Drug Administration’s (FDA) recent rejection of all study data from Mid-Link Testing highlights the importance of using reliable, ...

Faced with a complex regulatory landscape and intense public and investor scrutiny, financial institutions could use an ...

A team of scientist–sleuths has flagged data-integrity concerns in 130 studies authored by the same biomedical researcher, a specialist in women’s health and gynaecology, and his colleagues. The ...